Tag: venetoclax

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

Venetoclax demonstrates antitumor activity in relapsed CLL

byNeil D'Souzaand1 others

December 10, 2015

1. In this phase I trial, gradual dose escalation with selective BCL2 inhibitor, venetoclax, showed a manageable safety profile ...

Page 2 of 2 Prev 1 2

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism
Utilization of an early-life risk factor score to determine later life type 2 diabetes risk
Safety of investigational vaccines against human immunodeficiency virus

No Result

View All Result